Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OneSource Specialty PharmaNSE:ONESOURCE -2.14%8 Days Inventory is 281.45 as of Jun. 2026, which is 9% below its 10-year median of 309.38. GuruFocus rates NSE:ONESOURCE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 640 Biotechnology companies, OneSource Specialty Pharma ranks worse than 59.06% on this metric.
The historical rank and industry rank for OneSource Specialty Pharma's Days Inventory or its related term are showing as below:
NSE:ONESOURCE'
s Days Inventory Range Over the Past 10 Years
Min: 71.02 Med: 309.38 Max: 2381.18
Current: 226.05
During the past 4 years, OneSource Specialty Pharma's highest Days Inventory was 2381.18. The lowest was 71.02. And the median was 309.38.
NSE:ONESOURCE's Days Inventory is ranked worse than 59.06% of 640
companies
in the Biotechnology industry
Industry Median: 183.115
vs NSE:ONESOURCE: 226.05
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
OneSource Specialty Pharma's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
OneSource Specialty Pharma's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.98.
OneSource Specialty Pharma (NSE:ONESOURCE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
OneSource Specialty Pharma's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
OneSource Specialty Pharma's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
OneSource Specialty Pharma Days Inventory Related Terms
OneSource Specialty Pharma Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ONESOURCE vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, OneSource Specialty Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OneSource Specialty Pharma Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OneSource Specialty Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where OneSource Specialty Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OneSource Specialty Pharma (NSE:ONESOURCE) has a Days Inventory of 281.45 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on OneSource Specialty Pharma and its competitors. This is near median its historical median of 309.38. Over the past decade, OneSource Specialty Pharma's Days Inventory has ranged from 71.02 to 2,381.18. According to the industry distribution chart, OneSource Specialty Pharma ranks #378 out of 640 companies in the Biotechnology industry, placing it in the top 59.1%.
Is OneSource Specialty Pharma's Days Inventory too high?
OneSource Specialty Pharma's current Days Inventory of 281.45 is near median its 10-year median of 309.38. Over the past 10 years, this metric has ranged from a low of 71.02 to a high of 2,381.18. The Biotechnology industry median Days Inventory is 183.12. OneSource Specialty Pharma's value of 281.45 is 53.7% above this industry median. Based on the distribution chart, OneSource Specialty Pharma ranks #378 out of 640 companies in the Biotechnology industry, which is below the industry midpoint. Overall, OneSource Specialty Pharma has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does OneSource Specialty Pharma's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OneSource Specialty Pharma ranks #378 out of 640 companies for Days Inventory. This places OneSource Specialty Pharma in the lower half of its industry. The industry median Days Inventory is 183.12. OneSource Specialty Pharma's value of 281.45 is 53.7% above this benchmark. Historically, OneSource Specialty Pharma's own Days Inventory has ranged from 71.02 to 2,381.18 over the past decade. While the company's 10-year median is 309.38 vs. the industry median of 183.12, OneSource Specialty Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.12, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OneSource Specialty Pharma's current Days Inventory of 281.45 is 53.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on OneSource Specialty Pharma and its competitors. For the Biotechnology industry, the median Days Inventory is 183.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OneSource Specialty Pharma's current Days Inventory is 281.45, which is near median its own 10-year median of 309.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OneSource Specialty Pharma stock overvalued right now?
OneSource Specialty Pharma (NSE:ONESOURCE) has a current Days Inventory of 281.45. The current Days Inventory is 281.45, which is near median its 10-year median of 309.38 and 53.7% above the Biotechnology industry median of 183.12. OneSource Specialty Pharma's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For OneSource Specialty Pharma (NSE:ONESOURCE), the current Days Inventory is 281.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segments are CDMO (Contract Development and Manufacturing Organization (CDMO) : Development and manufacture of pharmaceutical products and associated services); and Unit-3 Multimodal Facility and CDMO-2.
8GF Score
Get the complete analysis for NSE:ONESOURCE
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ONESOURCE has been successfully added to your 
